An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg

AIM: To compare the effects of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg on HbA1c and body weight in patients with type 2 diabetes. MATERIALS AND METHODS: A Bucher indirect comparison was conducted to compare efficacy outcomes of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg using...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratley, Richard E., Catarig, Andrei‐Mircea, Lingvay, Ildiko, Viljoen, Adie, Paine, Abby, Lawson, Jack, Chubb, Barrie, Gorst‐Rasmussen, Anders, Miresashvili, Nino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291551/
https://www.ncbi.nlm.nih.gov/pubmed/34286894
http://dx.doi.org/10.1111/dom.14497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291551/
https://www.ncbi.nlm.nih.gov/pubmed/34286894
http://dx.doi.org/10.1111/dom.14497

Ejemplares similares